Form 4: Vaxart Chief Medical Officer James F. Cummings Reports Tax-Related Stock Disposal
SEC Form 4 Filing
James F. Cummings, Chief Medical Officer of Vaxart, Inc., reports the disposal of 3,292 shares of common stock to cover income tax obligations related to vested RSUs.
Summary
- On March 28, 2024, James F. Cummings, the Chief Medical Officer of Vaxart, Inc., disposed of 3,292 shares of common stock.
- The disposal was executed to satisfy income tax withholding obligations related to the net settlement of Restricted Stock Units (RSUs) that vested on the same date.
- The price per share was $1.3.
- Following the transaction, Cummings directly owns 326,801 shares of Vaxart common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine transaction related to tax obligations and doesn't indicate a change in the executive's sentiment towards the company.
Industry Context
Form 4 filings are standard disclosures required by the SEC to ensure transparency regarding insider transactions. This filing indicates a routine transaction related to tax obligations and doesn't necessarily reflect a change in the executive's long-term outlook on the company.
Key Dates
| Date | Description |
|---|---|
| 03/28/2024 | Date of transaction: Disposal of shares and vesting of RSUs. |
| 04/01/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.